192 related articles for article (PubMed ID: 31654986)
1. Fecal microbiota and metabolites are distinct in a pilot study of pediatric Crohn's disease patients with higher levels of perceived stress.
Mackner LM; Hatzakis E; Allen JM; Davies RH; Kim SC; Maltz RM; Bailey MT
Psychoneuroendocrinology; 2020 Jan; 111():104469. PubMed ID: 31654986
[TBL] [Abstract][Full Text] [Related]
2. Microbial and metabolic features associated with outcome of infliximab therapy in pediatric Crohn's disease.
Wang Y; Gao X; Zhang X; Xiao F; Hu H; Li X; Dong F; Sun M; Xiao Y; Ge T; Li D; Yu G; Liu Z; Zhang T
Gut Microbes; 2021; 13(1):1-18. PubMed ID: 33430702
[TBL] [Abstract][Full Text] [Related]
3. Variations in gut microbiota and fecal metabolic phenotype associated with depression by 16S rRNA gene sequencing and LC/MS-based metabolomics.
Yu M; Jia H; Zhou C; Yang Y; Zhao Y; Yang M; Zou Z
J Pharm Biomed Anal; 2017 May; 138():231-239. PubMed ID: 28219800
[TBL] [Abstract][Full Text] [Related]
4. Modulation of faecal metagenome in Crohn's disease: Role of microRNAs as biomarkers.
Rojas-Feria M; Romero-García T; Fernández Caballero-Rico JÁ; Pastor Ramírez H; Avilés-Recio M; Castro-Fernandez M; Chueca Porcuna N; Romero-Gόmez M; García F; Grande L; Del Campo JA
World J Gastroenterol; 2018 Dec; 24(46):5223-5233. PubMed ID: 30581271
[TBL] [Abstract][Full Text] [Related]
5. Exclusive enteral nutrition mediates gut microbial and metabolic changes that are associated with remission in children with Crohn's disease.
Diederen K; Li JV; Donachie GE; de Meij TG; de Waart DR; Hakvoort TBM; Kindermann A; Wagner J; Auyeung V; Te Velde AA; Heinsbroek SEM; Benninga MA; Kinross J; Walker AW; de Jonge WJ; Seppen J
Sci Rep; 2020 Nov; 10(1):18879. PubMed ID: 33144591
[TBL] [Abstract][Full Text] [Related]
6. Effects of bowel preparation on the human gut microbiome and metabolome.
Nagata N; Tohya M; Fukuda S; Suda W; Nishijima S; Takeuchi F; Ohsugi M; Tsujimoto T; Nakamura T; Shimomura A; Yanagisawa N; Hisada Y; Watanabe K; Imbe K; Akiyama J; Mizokami M; Miyoshi-Akiyama T; Uemura N; Hattori M
Sci Rep; 2019 Mar; 9(1):4042. PubMed ID: 30858400
[TBL] [Abstract][Full Text] [Related]
7. Timing for the second fecal microbiota transplantation to maintain the long-term benefit from the first treatment for Crohn's disease.
Li P; Zhang T; Xiao Y; Tian L; Cui B; Ji G; Liu YY; Zhang F
Appl Microbiol Biotechnol; 2019 Jan; 103(1):349-360. PubMed ID: 30357440
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive Analysis of the Relationships Between the Gut Microbiota and Fecal Metabolome in Individuals With Primary Sjogren's Syndrome by 16S rRNA Sequencing and LC-MS-Based Metabolomics.
Yang L; Xiang Z; Zou J; Zhang Y; Ni Y; Yang J
Front Immunol; 2022; 13():874021. PubMed ID: 35634334
[TBL] [Abstract][Full Text] [Related]
9. Integrated microbiome and metabolome analysis reveals a novel interplay between commensal bacteria and metabolites in colorectal cancer.
Yang Y; Misra BB; Liang L; Bi D; Weng W; Wu W; Cai S; Qin H; Goel A; Li X; Ma Y
Theranostics; 2019; 9(14):4101-4114. PubMed ID: 31281534
[No Abstract] [Full Text] [Related]
10. Impaired innate immune function associated with fecal supernatant from Crohn's disease patients: insights into potential pathogenic role of the microbiome.
Meelu P; Marin R; Clish C; Zella G; Cox S; Yajnik V; Nguyen DD; Korzenik JR
Inflamm Bowel Dis; 2014 Jul; 20(7):1139-46. PubMed ID: 24892965
[TBL] [Abstract][Full Text] [Related]
11. Systematic Analysis of Impact of Sampling Regions and Storage Methods on Fecal Gut Microbiome and Metabolome Profiles.
Liang Y; Dong T; Chen M; He L; Wang T; Liu X; Chang H; Mao JH; Hang B; Snijders AM; Xia Y
mSphere; 2020 Jan; 5(1):. PubMed ID: 31915218
[TBL] [Abstract][Full Text] [Related]
12. Fecal microbial dysbiosis in Chinese patients with inflammatory bowel disease.
Ma HQ; Yu TT; Zhao XJ; Zhang Y; Zhang HJ
World J Gastroenterol; 2018 Apr; 24(13):1464-1477. PubMed ID: 29632427
[TBL] [Abstract][Full Text] [Related]
13. A Distinct Gut Microbiota Exists Within Crohn's Disease-Related Perianal Fistulae.
Haac BE; Palmateer NC; Seaton ME; VanYPeren R; Fraser CM; Bafford AC
J Surg Res; 2019 Oct; 242():118-128. PubMed ID: 31075656
[TBL] [Abstract][Full Text] [Related]
14. Reduced Abundance of Butyrate-Producing Bacteria Species in the Fecal Microbial Community in Crohn's Disease.
Takahashi K; Nishida A; Fujimoto T; Fujii M; Shioya M; Imaeda H; Inatomi O; Bamba S; Sugimoto M; Andoh A
Digestion; 2016; 93(1):59-65. PubMed ID: 26789999
[TBL] [Abstract][Full Text] [Related]
15. Fecal microbiota transplantation through mid-gut for refractory Crohn's disease: safety, feasibility, and efficacy trial results.
Cui B; Feng Q; Wang H; Wang M; Peng Z; Li P; Huang G; Liu Z; Wu P; Fan Z; Ji G; Wang X; Wu K; Fan D; Zhang F
J Gastroenterol Hepatol; 2015 Jan; 30(1):51-8. PubMed ID: 25168749
[TBL] [Abstract][Full Text] [Related]
16. Fecal Microbiota Signatures Are Associated with Response to Ustekinumab Therapy among Crohn's Disease Patients.
Doherty MK; Ding T; Koumpouras C; Telesco SE; Monast C; Das A; Brodmerkel C; Schloss PD
mBio; 2018 Mar; 9(2):. PubMed ID: 29535202
[TBL] [Abstract][Full Text] [Related]
17. Faecal Microbiota Dynamics and their Relation to Disease Course in Crohn's Disease.
Galazzo G; Tedjo DI; Wintjens DSJ; Savelkoul PHM; Masclee AAM; Bodelier AGL; Pierik MJ; Jonkers DMAE; Penders J
J Crohns Colitis; 2019 Sep; 13(10):1273-1282. PubMed ID: 30810207
[TBL] [Abstract][Full Text] [Related]
18. The gastric microbiota in patients with Crohn's disease; a preliminary study.
Ostrowski J; Kulecka M; Zawada I; Żeber-Lubecka N; Paziewska A; Graca-Pakulska K; Dąbkowski K; Skubisz K; Cybula P; Ambrożkiewicz F; Urasińska E; Mikula M; Starzyńska T
Sci Rep; 2021 Sep; 11(1):17866. PubMed ID: 34504159
[TBL] [Abstract][Full Text] [Related]
19. Associations of NOD2 polymorphisms with Erysipelotrichaceae in stool of in healthy first degree relatives of Crohn's disease subjects.
Turpin W; Bedrani L; Espin-Garcia O; Xu W; Silverberg MS; Smith MI; Garay JAR; Lee SH; Guttman DS; Griffiths A; Moayyedi P; Panaccione R; Huynh H; Steinhart HA; Aumais G; Dieleman LA; Turner D; ; Paterson AD; Croitoru K
BMC Med Genet; 2020 Oct; 21(1):204. PubMed ID: 33059653
[TBL] [Abstract][Full Text] [Related]
20. Multi-omics differentially classify disease state and treatment outcome in pediatric Crohn's disease.
Douglas GM; Hansen R; Jones CMA; Dunn KA; Comeau AM; Bielawski JP; Tayler R; El-Omar EM; Russell RK; Hold GL; Langille MGI; Van Limbergen J
Microbiome; 2018 Jan; 6(1):13. PubMed ID: 29335008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
